ClinicalTrials.gg
Not yet recruitingNCT07324590Updated Jan 7, 2026

Thermal Imaging in the Diagnosis of Acute Testicular Pain

An interventional study of Thermidas thermal camera in Testicular Diseases, sponsored by Seinajoki Central Hospital. Not yet recruiting at 1 site in Finland. Open to male participants. Per ClinicalTrials.gov, last updated 2026-01-07.

Sponsored by Seinajoki Central Hospital · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Not applicable
Sex
Male
01

Study summary

Acute scrotal pain due to testicular torsion is a rare but urgent urological condition that requires immediate surgery to prevent permanent damage or loss of the testicle. Early detection is crucial to minimize delays from the onset of pain to operative treatment. The diagnosis of torsion involves a combination of physical examination and imaging studies, such as Doppler ultrasound (DU). However, DU requires an experienced radiologist and may cause unnecessary time delays. Thermal imaging is a noninvasive technique that can detect skin surface temperature variations using a highly sensitive infrared camera. Although there are some promising animal studies using thermal imaging for the diagnosis of testicular ischemia, number of studies in humans is very limited.

According to a small pilot study in 2024, thermal imaging is a fast, feasible and noninvasive diagnostic tool that seems to have considerable potential in the evaluation of patients with acute testicular pain, especially those with symptoms of testicular torsion. However, further research with a larger sample size is needed. In this multicenter study, the investigators aim is to determine the role of thermal imaging in the diagnosis of acute testicular pain.

Males with acute testicular pain entering emergency are included. After informed consent thermal image of testicles will be taken before any additional investigations such as laboratory tests and DU. Participants are treated as usual and testicular temperatures will be correlated with final diagnosis after approximately 6-month study period is over.

Read the detailed description

Acute testicular pain can have several causes, such as testicular torsion, but current diagnostic methods, such as DU, may be time-consuming and operator-dependent. The aim of this study is to evaluate the use of thermal imaging as a diagnostic tool for acute testicular pain, particularly in diagnosing testicular torsion, which requires urgent surgical treatment. Thermal imaging is a quick and non-invasive alternative that may help to reduce diagnostic delays. Results from two animal studies and a small pilot study conducted on patients in 2024 suggest that a thermal camera may be able to distinguish testicular torsion from epididymitis, which is another common cause for acute testicular pain. This multicenter study investigates the usability, accuracy, operator independence, and clinical applicability of thermal imaging in diagnosing acute testicular pain. According to a preliminary calculation, at least 146 participants are required with 80% statistical power and a 5% error rate. The sample size will be reassessed after six months, and if necessary, the enrollment phase will be extended.

A prospective 6-month study on the use and feasibility of thermal imaging for the diagnosing the cause of acute testicular pain will be conducted. Participating centers will include all university hospitals in Finland (Helsinki, Turku, Oulu, Tampere and Kuopio) and central hospitals of Seinäjoki, Jyväskylä and Pori. The study population will include all male participants presenting with acute testicular pain.

Participants with testicular pain are examined with thermal imaging immediately after arriving in the emergency department and before any other examinations (e.g., laboratory tests, DU). The results of the thermal imaging are not used in clinical decision-making; instead, they are compared later with the final diagnosis. Thermal imaging therefore does not influence the examinations or treatment decisions made for the participants, nor does it expose the participants to harmful ionizing radiation.

After entering the emergency room, the participants are verbally informed of the ongoing study and given research information sheet and preparatory instructions concerning the potential thermal imaging. The instructions explain how to tape the penis upward against the abdomen for 5 minutes to eliminate its thermal effect on the thermal image of the testicles. The trained and delegated research staff members give further verbal information about the study and the thermal imaging. Afterwards they collect the verbal permission and a signed informed consent form to take the thermal image. Participant's social security number, date, time and the code of the thermal image are written down on the consent form, which is stored in a secure place for safekeeping. Duplicate of the consent form remains with the participants. The estimated time needed for taking the thermal image is few minutes. Temperature results, however, will have no effect on decision making, as participants will be diagnosed and treated as usual using established routine diagnostic tools such as clinical evaluation, laboratory and urinary testing and DU.

A class IIa CE-approved Thermidas handheld camera (IRT-384 Tablet) will be used. It is designed for healthcare professionals to monitor and evaluate skin surface temperatures. The company Thermidas will educate our research staff in the use of their thermal camera. The leasing cost is 500 € per camera per month and it is covered by reaserch funf of Tampere University Hospital. The role of the company Thermidas in this study is to solely provide the thermal cameras for a fee, including the education in the use of the camera, and to store the images securely. The investigators have got a authorization for medicinal device from Fimea and approval from the ethics committee of Tampere University Hospital.

Technical specifications of the IRT-384 camera:

  • Tablet operatin system: android
  • Thermography sofware: Thermidas VistaClinic
  • Display size: 10.1"
  • Display resolution and colors: 1920 x 1200 pixels, 16 M colors
  • RAM and ROM: 4 Gb and 64 Gb
  • Connectivity: Wi-Fi
  • Thermal camera resolution: 384 x 288 pixels
  • Total active pixels: 110592
  • Thermal Sensitivity(NETD: \<0.05 C @ 30 C
  • Accuracy: +- 2 C
  • Field of View: 41.5 x 31.1
  • Weight: 1.4 kg

The distance from the camera to the scrotum is approximately 20 cm while participant is standing, and testicles are hanging freely. Results of thermal imaging (temperature difference between testicles in Celsius) will be correlated with final diagnose at the end of study. Thermal picture (testicular temperatures) will be analyzed by two independent investigators blinded to each other and results will be correlated with the final diagnoses. SPSS statistical software will be used and sensitivity and specificity for thermal imaging will be calculated. Study registry holder will be Central Hospital of Seinäjoki.

Sub-study 1 Adult participants having funicular orchiectomy due to testicular cancer will be included. At operation thermal picture of untouched testicles will be taken before ligation or closure of the funicle (baseline) and at 5, 10 and 15 minutes afterwards. After this, funicular orchiectomy is performed as usual.

02

Conditions studied

  • Testicular Diseases

Keywords

  • Testicular torsion
  • epididymites
  • testicular appendages torsion
  • Testicular pain
03

In context

Lead sponsor

Seinajoki Central Hospital is the lead sponsor of 6 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Males, who come to emergency department due to acute testicular pain and sign .

Sub-study 1: Adult males, who are having funicular orchiectomy due to testicular cancer and sign informed consent.

Exclusion criteria

Exclusion Criteria:

  • Previous surgery or other operative procedure such as puncture in scrotal area within 30 days.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Patients with acute testicular pain

    Device: Thermidas thermal camera

Interventions

  • DeviceThermidas thermal camera

    This kind of study has not been perfomed before

06

What researchers measure

Primary outcomes

  1. To determine role of thermal imaging in the diagnoses of acute testicular pain. To evaluate the effect of funicular ligation on testicular temperature (substudy 1).

    Temperatures of testicles * Comparison of temperatures (temperature diffrence) in Celsius of symptomatic and asymptomatic testicles * Temperatures of testicle in Celsius before and 5, 10 and 15 minutes after ligation of funicle (substudy 1)

    Time frame: Thermal picture is taken once at baseline. In substudy 1, thermal pictures of testicle will be taken at 0, 5, 10 and 15 minutes

07

Study locations

1 site
  • Hanneksenrinne 7
    Seinäjoki, 60220, Finland
08

References and documents

Publications

  • Brooks JP, Brooks JM, Seals T. Smartphone Thermal Imaging in the Detection of Testicular Ischemia. Urology. 2021 Nov;157:233-238. doi: 10.1016/j.urology.2021.02.031. Epub 2021 Mar 6. PubMed 33689763 ↗

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Clinical study report

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2026; primary completion for Aug 2026, 7 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 21, 2025
First posted
Jan 7, 2026
StartEst.
Jan 1, 2026
Primary completionEst.
Aug 30, 2026
CompletionEst.
Dec 31, 2026
Last update
Jan 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07324590
Lead sponsor
Seinajoki Central Hospital
Collaborators
Hospital District of Helsinki and Uusimaa, Turku University Hospital, Kuopio University Hospital, Oulu University Hospital, Tampere University Hospital, Pori Central Hospital, Jyväskylä Central Hospital
Responsible party
Mika Raitanen (Associate Professor, chief clinician, Seinajoki Central Hospital) — Principal investigator
First posted
Jan 7, 2026
Start date
Jan 1, 2026 (estimated)
Primary completion
Aug 30, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jan 7, 2026

Study contacts

Mika P Raitanen, M.D, Ph.D, associate professor
Contact
mika.raitanen@hyvaep.fi
+358 40 5123068 ext. +358 6 4154953
Mika P Raitanen, M.D., Ph.D, associate prof
study chair · Seinöjoki Central Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion